-
1
المؤلفون: Chiam, Paul Toon Lim, Chan, Nien Shen, Lim, Yean Teng, Lim, Choon Pin, Nair, Dinesh, Lim, Tai Tian, Soon, Chao Yang, Khoo, Brian Chung Hoe, Lim, Jimmy, Tan, Kok Soon, Lam, Leslie, Yan, Peter, Ooi, Yau Wei, Chong, Mei Sian
المصدر: Singapore Med J
مصطلحات موضوعية: Aged, 80 and over, Male, Aortic Valve Stenosis, General Medicine, Prosthesis Design, Stroke, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve, Heart Valve Prosthesis, Humans, Original Article, Female, Asia, Southeastern, Aged
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e90982d5206510092e8c0b59d2e9862c
https://doi.org/10.11622/smedj.2022030 -
2دورية أكاديمية
المؤلفون: Zhang, Li, Bapna, Akanksha, Shim, Winston, El, Oakley Reida, Lim, Yean Teng, Lim, Tai Tian, Teh, Ming, Ge, Ruowen, Sim, Eugene
المصدر: Journal of Cardiac Surgery; Nov2002, Vol. 17 Issue 6, p561-561, 1p
-
3دورية أكاديمية
المؤلفون: Wong A; Department of Cardiology, National Heart Centre, Singapore. aaron_wong@nhc.com.sg, Mak KH, Chan C, Koh TH, Lau KW, Lim TT, Lim ST, Wong P, Sim LL, Lim YT, Tan HC, Lim YL
المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2004 Aug; Vol. 62 (4), pp. 445-52.
نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE
مواضيع طبية MeSH: Angioplasty, Balloon, Coronary*/adverse effects , Angioplasty, Balloon, Coronary*/instrumentation , Stents*, Antibodies, Monoclonal/*therapeutic use , Fibrinolytic Agents/*therapeutic use , Immunoglobulin Fab Fragments/*therapeutic use , Myocardial Infarction/*therapy , Platelet Aggregation Inhibitors/*therapeutic use , Tissue Plasminogen Activator/*therapeutic use, Abciximab ; Aged ; Antibodies, Monoclonal/adverse effects ; Cardiovascular Diseases/etiology ; Combined Modality Therapy ; Coronary Angiography ; Coronary Circulation ; Drug Therapy, Combination ; Feasibility Studies ; Female ; Fibrinolytic Agents/administration & dosage ; Fibrinolytic Agents/adverse effects ; Hemorrhage/chemically induced ; Humans ; Immunoglobulin Fab Fragments/adverse effects ; Male ; Middle Aged ; Myocardial Infarction/diagnostic imaging ; Myocardial Infarction/drug therapy ; Myocardial Infarction/physiopathology ; Pilot Projects ; Platelet Aggregation Inhibitors/adverse effects ; Research Design ; Singapore ; Time Factors ; Tissue Plasminogen Activator/administration & dosage ; Tissue Plasminogen Activator/adverse effects ; Treatment Outcome